460 related articles for article (PubMed ID: 32209110)
1. Prevalence and risk factors associated with HIV-1 infection among people who inject drugs in Dar es Salaam, Tanzania: a sign of successful intervention?
Likindikoki SL; Mmbaga EJ; Leyna GH; Moen K; Makyao N; Mizinduko M; Mwijage AI; Faini D; Leshabari MT; Meyrowitsch DW
Harm Reduct J; 2020 Mar; 17(1):18. PubMed ID: 32209110
[TBL] [Abstract][Full Text] [Related]
2. HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination.
Leyna GH; Makyao N; Mwijage A; Ramadhan A; Likindikoki S; Mizinduko M; Leshabari MT; Moen K; Mmbaga EJ
Harm Reduct J; 2019 Dec; 16(1):68. PubMed ID: 31829199
[TBL] [Abstract][Full Text] [Related]
3. Socio-cognitive factors influencing access to HIV prevention services among people who inject drugs in Dar es Salaam, Tanzania: An integrated bio-behavioural survey.
Likindikoki SL; Meyrowitsch DW; Mizinduko MM; Ishungisa AM; Tersbøl BP; Leyna GH; Moen K; Makyao N; Lange T; Leshabari MT; Mmbaga EJ
PLoS One; 2022; 17(1):e0261500. PubMed ID: 35089928
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of human immunodeficiency virus, hepatitis B and C viral infections among people who inject drugs: a potential stumbling block in the control of HIV and viral hepatitis in Tanzania.
Kawambwa RH; Majigo MV; Mohamed AA; Matee MI
BMC Public Health; 2020 Feb; 20(1):177. PubMed ID: 32019536
[TBL] [Abstract][Full Text] [Related]
5. Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania.
Fraser H; Stone J; Wisse E; Sambu V; Mfisi P; Duran IJ; Soriano MA; Walker JG; Makere N; Luhmann N; Kafura W; Nouvellet M; Ragi A; Mundia B; Vickerman P
J Int AIDS Soc; 2021 Oct; 24(10):e25817. PubMed ID: 34661964
[TBL] [Abstract][Full Text] [Related]
6. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors of HIV infection among people who inject drugs in Cambodia: findings from a national survey.
Mburu G; Chhoun P; Chann N; Tuot S; Mun P; Yi S
Subst Abuse Treat Prev Policy; 2019 Oct; 14(1):42. PubMed ID: 31623645
[TBL] [Abstract][Full Text] [Related]
8. Generating trust: Programmatic strategies to reach women who inject drugs with harm reduction services in Dar es Salaam, Tanzania.
Zamudio-Haas S; Mahenge B; Saleem H; Mbwambo J; Lambdin BH
Int J Drug Policy; 2016 Apr; 30():43-51. PubMed ID: 26880500
[TBL] [Abstract][Full Text] [Related]
9. Young people who inject drugs in India have high HIV incidence and behavioural risk: a cross-sectional study.
Ganapathi L; McFall AM; Srikrishnan AK; Kumar MS; Anand S; Lucas GM; Mehta SH; Harris SK; Solomon SS
J Int AIDS Soc; 2019 May; 22(5):e25287. PubMed ID: 31116005
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
[TBL] [Abstract][Full Text] [Related]
11. HIV prevalence and risk behaviors among people who inject drugs in two serial cross-sectional respondent-driven sampling surveys, Zanzibar 2007 and 2012.
Matiko E; Khatib A; Khalid F; Welty S; Said C; Ali A; Othman A; Haji S; Kibona M; Kim E; Broz D; Dahoma M
AIDS Behav; 2015 Feb; 19 Suppl 1(Suppl 1):S36-45. PubMed ID: 25399032
[TBL] [Abstract][Full Text] [Related]
12. HIV prevalence among men who have sex with men following the implementation of the HIV preventive guideline in Tanzania: respondent-driven sampling survey.
Alexander Ishungisa M; Moen K; Leyna G; Makyao N; Ramadhan A; Lange T; Meyrowitsch DW; Mizinduko M; Likindikoki S; Leshabari M; Mmbaga EJ
BMJ Open; 2020 Oct; 10(10):e036460. PubMed ID: 33020084
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Predictors of Human Immunodeficiency Virus and Selected Sexually Transmitted Infections Among People Who Inject Drugs in Dar es Salaam, Tanzania: A New Focus to Get to Zero.
Mmbaga EJ; Moen K; Makyao N; Leshabari M
Sex Transm Dis; 2017 Feb; 44(2):79-84. PubMed ID: 27984553
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania.
Lambdin BH; Lorvick J; Mbwambo JK; Rwegasha J; Hassan S; Lum P; Kral AH
Int J Drug Policy; 2017 Jul; 45():64-69. PubMed ID: 28628854
[TBL] [Abstract][Full Text] [Related]
15. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico.
Ospina-Escobar A; Magis-Rodríguez C; Juárez F; Werb D; Bautista Arredondo S; Carreón R; Ramos ME; Strathdee S
Harm Reduct J; 2018 May; 15(1):27. PubMed ID: 29776368
[TBL] [Abstract][Full Text] [Related]
16. A Mismatch between High-Risk Behaviors and Screening of Infectious Diseases among People Who Inject Drugs in Dar es Salaam, Tanzania.
Mlunde LB; Sunguya BF; Mbwambo JK; Ubuguyu OS; Shibanuma A; Yasuoka J; Jimba M
PLoS One; 2016; 11(2):e0148598. PubMed ID: 26849802
[TBL] [Abstract][Full Text] [Related]
17. Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugs.
Prouté M; Le Coeur S; Tiv MH; Dub T; Jongpaijitsakul P; Ratnamhin A; Angkurawaranon C; Aramrattana A; Lallemant M
BMC Public Health; 2020 Sep; 20(1):1450. PubMed ID: 32972359
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of HIV/Hepatitis C Virus Co-Infection and Injection Risk Correlations in People Who Inject Drugs in Colombia: A Cross-Sectional Study Using Respondent Driven Sampling.
Toro-Tobón D; Berbesi-Fernández D
Subst Use Misuse; 2020; 55(3):414-423. PubMed ID: 31691646
[No Abstract] [Full Text] [Related]
19. Prevalence of hepatitis C virus in young people who inject drugs in four Colombian cities: A cross-sectional study using Respondent Driven Sampling.
Toro-Tobón D; Berbesi-Fernandez D; Mateu-Gelabert P; Segura-Cardona ÁM; Montoya-Vélez LP
Int J Drug Policy; 2018 Oct; 60():56-64. PubMed ID: 30107313
[TBL] [Abstract][Full Text] [Related]
20. Upscaling prevention, testing and treatment to control hepatitis C as a public health threat in Dar es Salaam, Tanzania: A cost-effectiveness model.
Scott N; Mohamed Z; Rwegasha J; Mbwambo J; Lemoine M; Hellard M
Int J Drug Policy; 2021 Feb; 88():102634. PubMed ID: 31882272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
